专利检索 ap:"TIANJIN PEGYLATT BIOTECHNOLOGY CO., LTD" 第 1 页

1.

发明公开
METHODS FOR EFFECTIVE AND SAFE TREATMENT OF NEUTROPENIA USING DE-MOBILIZED G-CSF 审中-公开

公开(公告)号：US20240245752A1

公开(公告)日：2024-07-25

申请号：US16538853

申请日：2019-08-13

申请人： TIANJIN PEGYLATT BIOTECHNOLOGY CO., LTD

发明人： Xuan Zhang

IPC分类号： A61K38/19 , A61K9/00 , A61K38/38 , A61K47/60 , A61P7/00

CPC分类号： A61K38/193 , A61K9/0019 , A61K38/38 , A61K47/60 , A61P7/00

摘要： The present invention provides a method to treat and/or prevent febrile neutropenia and Grade 3/4 neutropenia. The method comprises application a Declined mobilizing granulocyte colony-stimulating factor (De-mobilized G-CSF) at a selected time, and a controlled dosage depended on the severity of neutropenia. The present invention also provides evidences to identify the De-mobilized G-CSF and High-mobilized G-CSF, and a method for preparing the De-mobilized G-CSF.